↓ Skip to main content

Cochrane Database of Systematic Reviews

Antipsychotic drug treatment for elderly people with late‐onset schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, February 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
8 X users

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
181 Mendeley
Title
Antipsychotic drug treatment for elderly people with late‐onset schizophrenia
Published in
Cochrane database of systematic reviews, February 2012
DOI 10.1002/14651858.cd004162.pub2
Pubmed ID
Authors

Adib Essali, Ghassan Ali

Abstract

Schizophrenia is usually considered an illness of young adulthood. However, onset after the age of 40 years is reported in 23% of patients hospitalised with schizophrenia. At least 0.1% of the world's elderly population have a diagnosis of late-onset schizophrenia which seems to differ from earlier onset schizophrenia on a variety of counts including response to antipsychotic drugs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
India 1 <1%
Unknown 179 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 15%
Researcher 22 12%
Student > Ph. D. Student 20 11%
Student > Bachelor 19 10%
Student > Postgraduate 13 7%
Other 30 17%
Unknown 50 28%
Readers by discipline Count As %
Medicine and Dentistry 53 29%
Psychology 27 15%
Nursing and Health Professions 16 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Neuroscience 5 3%
Other 19 10%
Unknown 55 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2018.
All research outputs
#2,626,064
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#5,203
of 11,499 outputs
Outputs of similar age
#20,214
of 258,519 outputs
Outputs of similar age from Cochrane database of systematic reviews
#65
of 204 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,519 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.